Capricor Therapeutics Inc (CAPR.OQ)
CAPR.OQ on NASDAQ Stock Exchange Capital Market
1.33USD
23 Jul 2018
1.33USD
23 Jul 2018
Change (% chg)
$0.01 (+0.76%)
$0.01 (+0.76%)
Prev Close
$1.32
$1.32
Open
$1.31
$1.31
Day's High
$1.33
$1.33
Day's Low
$1.31
$1.31
Volume
2,946
2,946
Avg. Vol
39,506
39,506
52-wk High
$4.25
$4.25
52-wk Low
$0.91
$0.91
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 0.40 | -0.136 |
| FY 2017 | Dec '17 | 0.48 | 0.306 |
| Sep '17 | 0.31 | -0.117 | |
| Jun '17 | 1.00 | -0.157 | |
| Mar '17 | 0.88 | -0.171 | |
| FY 2016 | Dec '16 | 0.91 | -0.211 |
| Sep '16 | 0.75 | -0.292 | |
| Jun '16 | 1.13 | -0.261 | |
| Mar '16 | 1.22 | -0.258 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 2 | 0.45 | 0.90 | 0.00 | -- |
| Quarter Ending Dec-18 | 2 | 0.51 | 1.02 | 0.00 | -- |
| Year Ending Dec-18 | 2 | 1.55 | 2.70 | 0.40 | 6.90 |
| Year Ending Dec-19 | 2 | 1.40 | 2.80 | 0.00 | 7.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 2 | -0.12 | -0.11 | -0.14 | -- |
| Quarter Ending Dec-18 | 2 | -0.12 | -0.11 | -0.14 | -- |
| Year Ending Dec-18 | 2 | -0.50 | -0.48 | -0.53 | -0.83 |
| Year Ending Dec-19 | 2 | -0.44 | -0.44 | -0.45 | -0.84 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 85.33 | 32.76 | |
| P/E High - Last 5 Yrs. | -- | 298.33 | 45.44 | |
| P/E Low - Last 5 Yrs. | -- | 91.43 | 24.26 | |
| Beta | -2.65 | 0.93 | 0.89 | |
| Price to Sales (TTM) | 19.03 | 112.52 | 5.73 | |
| Price to Book (MRQ) | -- | 15.54 | 5.47 | |
| Price to Tangible Book (MRQ) | -- | 14.64 | 7.05 | |
| Price to Cash Flow (TTM) | -- | 72.59 | 23.29 | |
| % Owned Institutions | 3.23 | 14.53 | 2.21 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.35 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.27 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 1.70 | 5.22 | |
| Payout Ratio(TTM) | -- | 16.35 | 43.77 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -11.80 | 408.02 | 8.01 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -26.18 | 79.88 | 5.64 | |
| Sales - 5 Yr. Growth Rate | 24.17 | 32.06 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 39.94 | 29.02 | 20.60 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 8.12 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 39.49 | 10.66 | |
| Capital Spending - 5 Yr. Growth Rate | 149.85 | 39.97 | 15.33 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.92 | 2.22 |
| Current Ratio (MRQ) | 0.82 | 5.50 | 3.03 |
| LT Debt to Equity (MRQ) | -- | 34.92 | 12.51 |
| Total Debt to Equity (MRQ) | -- | 36.72 | 16.84 |
| Interest Coverage (TTM) | -58.74 | -101.16 | 32.64 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 39.68 | 54.37 | |
| Gross Margin - 5 Yr. Avg. | -- | 50.98 | 52.17 | |
| EBITD Margin (TTM) | -423.45 | -- | -- | |
| EBITD - 5 Yr. Avg | -265.04 | -586.56 | 10.81 | |
| Operating Margin (TTM) | -470.06 | -733.21 | 4.58 | |
| Operating Margin - 5 Yr. Avg. | -287.51 | -608.15 | 6.23 | |
| Pre-Tax Margin (TTM) | -481.18 | -707.36 | 5.43 | |
| Pre-Tax Margin - 5 Yr. Avg. | -292.39 | -611.67 | 6.67 | |
| Net Profit Margin (TTM) | -481.18 | -708.75 | 1.73 | |
| Net Profit Margin - 5 Yr. Avg. | -292.39 | -614.69 | 2.94 | |
| Effective Tax Rate (TTM) | -- | 23.23 | 23.11 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.56 | 23.98 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 23,025,841 | 860,394,083 | |
| Net Income/Employee (TTM) | -- | 3,117,868 | 101,209,433 | |
| Receivable Turnover (TTM) | 13.29 | 20.74 | 5.87 | |
| Inventory Turnover (TTM) | -- | 2.46 | 3.41 | |
| Asset Turnover (TTM) | 0.25 | 0.41 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -120.88 | 0.27 | 11.14 | |
| Return on Assets - 5 Yr. Avg. | -96.30 | 3.72 | 12.40 | |
| Return on Investment (TTM) | -645.84 | 2.22 | 14.61 | |
| Return on Investment - 5 Yr. Avg. | -149.85 | 2.89 | 16.14 | |
| Return on Equity (TTM) | -- | 3.86 | 16.34 | |
| Return on Equity - 5 Yr. Avg. | -- | 3.83 | 17.40 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -27.53 | 99.55 | 24.17 |
| EPS (TTM) % | -25.39 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Capricor Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 177.67 | 168.10 | 99 | 53 |
| 13 Week | 326.87 | 306.08 | 99 | 66 |
| 26 Week | -0.69 | -8.24 | 99 | 79 |
| 52 Week | -15.13 | -28.07 | 77 | 52 |
| YTD | 7.52 | -5.58 | 99 | 61 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 8.19% |
| # of Holders: | 24 |
| Total Shares Held: | 2,384,074 |
| 3 Mo. Net Change: | 0 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 0 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.